5434272025-10-012025-12-315434272025-12-315434272025-04-012025-12-315434272025-10-012025-12-31in-capmkt:OtherExpenses1Member5434272025-04-012025-12-31in-capmkt:OtherExpenses1Member5434272025-10-012025-12-31in-capmkt:ReportableSegments1Member5434272025-10-012025-12-31in-capmkt:ReportableSegments2Member5434272025-10-012025-12-31in-capmkt:ReportableSegments3Member5434272025-04-012025-12-31in-capmkt:ReportableSegments1Member5434272025-04-012025-12-31in-capmkt:ReportableSegments2Member5434272025-04-012025-12-31in-capmkt:ReportableSegments3Member5434272025-10-012025-12-31in-capmkt:ReportableSegments1Member5434272025-10-012025-12-31in-capmkt:ReportableSegments2Member5434272025-10-012025-12-31in-capmkt:ReportableSegments3Member5434272025-04-012025-12-31in-capmkt:ReportableSegments1Member5434272025-04-012025-12-31in-capmkt:ReportableSegments2Member5434272025-04-012025-12-31in-capmkt:ReportableSegments3Member5434272025-10-012025-12-31in-capmkt:ReportableSegments1Member5434272025-12-31in-capmkt:ReportableSegments1Member5434272025-10-012025-12-31in-capmkt:ReportableSegments2Member5434272025-12-31in-capmkt:ReportableSegments2Member5434272025-10-012025-12-31in-capmkt:ReportableSegments3Member5434272025-12-31in-capmkt:ReportableSegments3Member5434272025-10-012025-12-31in-capmkt:ReportableSegments1Member5434272025-12-31in-capmkt:ReportableSegments1Member5434272025-10-012025-12-31in-capmkt:ReportableSegments2Member5434272025-12-31in-capmkt:ReportableSegments2Member5434272025-10-012025-12-31in-capmkt:ReportableSegments3Member5434272025-12-31in-capmkt:ReportableSegments3Member5434272025-10-012025-12-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares543427MEDPLUSNOTLISTEDINE804L01022Medplus Health Services LimitedMain BoardEquity2025-04-012026-03-312026-01-302026-01-03INRMillionsQuarterlyThird quarterMulti segment2026-01-3014:30:002026-01-3016:45:00Declaration of unmodified opinion2025-10-012025-12-31UnauditedConsolidated180611800001824100001824359000020519000013615030000-4834600002326480000308290000727410000811780000175107200007328700000732870000206500000-51510000154990000057788000000005778800000577880000578070000-190000578070000-19000023964000024.824.81004.824.811.The above unaudited consolidated financial results of MedPlus Health Services Limited ('the Company') and its subsidiaries (together referred as 'The Group') have been prepared in accordance with Indian Accounting Standards ('Ind AS') prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“listing regulations”) from time to time. These unaudited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meetings held on January 30, 2026. These financial results have been subjected to limited review by the Statutory Auditors of the Company and the auditors have expressed and issued an unmodified review report on the same. <BR> 2.During the year ended March 31, 2022, the Company has completed its Initial Public Offering (IPO) of 17,573,342 equity shares of face value of Rs. 2 each for cash at an issue price of Rs. 796 per equity share aggregating to Rs. 13,982.95 million, consisting of Fresh Issue of 7,544,511 equity shares amounting to Rs. 6,000 million and an offer for sale of 10,028,831 equity shares amounting to Rs. 7,982.95 million by the Selling Shareholders. Pursuant to the IPO, the equity shares of the Company were listed on National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) with effect from December 23, 2021. <BR> The utilization of IPO proceeds received by the Company (net of IPO related expense) is summarized below: <BR> (Rs. In Millions) <BR> Objects as per Prospectus Planned utilisation as per Prospectus Utilisation up to <BR> December 31, 2025 Unutilised amount as on December 31, 2025* <BR> i) Investment in Subsidiary - Optival Health Solutions Private Limited towards their working capital requirements 4,671.70 4,671.70 - <BR> ii) General Corporate Purposes 1,117.63 1,095.13 22.50 <BR> Total 5,789.33 5,766.83 22.50 <BR> * The aforesaid unutilised proceeds of Rs. 22.50 million have been placed as fixed deposits with bank. <BR> 3.On November 21, 2025, the Government of India notified the four Labour Codes - the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020, and the Occupational Safety, Health and Working Conditions Code, 2020 - consolidating 29 existing labour laws. The Ministry of Labour & Employment published draft Central Rules and FAQs to enable assessment of the financial impact due to changes in regulations. The Company has assessed and recorded the incremental impact of these changes amounting to INR 70.59 million as employee benefits expense. The Company continues to monitor the finalisation of Central / State Rules and clarifications from the Government on other aspects of the Labour Code and would provide appropriate accounting effect on the basis of such developments as needed. <BR> 4.The earnings per equity share for the quarters and nine months ended are not annualised. <BR> 5.The above financial results are also available at the Stock Exchange's website i.e. www.bseindia.com, www.nseindia.com and the Company's website www.medplusindia.com. <BR> For and on behalf of the Board of Directors of <BR> MedPlus Health Services Limited <BR> G. Madhukar Reddy <BR> Managing Director and Chief Executive Officer <BR> DIN: 00098097 <BR> Place: Hyderabad <BR> Date: January 30, 20262025-04-012025-12-31UnauditedConsolidated50280810000507290000507881000006310500003635349000015209000064641100008701300002069210000229814000048838220000194988000001949880000552720000-1591700003935500000155633000000001556330000015563300001556660000-3300001556660000-330000239640000212.9912.960012.9912.96Other Expenses811780000Other Expenses2298140000a. Retail17733700000b. Diagnostics Services326670000c. Others810000a. Retail49311300000b. Diagnostics Services962070000c. Others74400001806118000050280810000001806118000050280810000a. Retail641300000b. Diagnostics Services4920000c. Others-1730000a. Retail1682880000b. Diagnostics Services7760000c. Others24300006444900001693070000180000290000-88560000-2571000007328700001949880000a. Retail29015360000b. Diagnostics Services1433150000c. Others680000030455310000682847000037283780000a. Retail17222570000b. Diagnostics Services1031020000c. Others169000018255280000018255280000000000UnauditedtrueB S R and Cotrue2026-04-30